Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
AZN:LNLondon

AstraZeneca PLC

COMPANY INFO
7,418.00GBp
+38.00+0.51%
Market Closed
As of 04/19/2021 EDT
Open
7,348.00
Prev Close
7,380.00
Volume
2,389,496
Market Cap
97.379B
Day Range
7,301.007,446.00
52 Week Range
6,736.0010,120.00
1D1M1Y5Y
View Full Chart
Market Closed
As of 04/19/2021 EDT
1D1M1Y5Y
View Full Chart
News
Press Releases
business
EU Divided on How to Use the AstraZeneca Covid Vaccine
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio42.54
PEGY Ratio2.0221
Shares Outstanding1.31B
Price to Book Ratio8.7242
Price to Sales Ratio5.1178
1 Year Return-4.37%
30 Day Avg Volume2,231,042
EPS2.44
Dividend2.75%
Last Dividend Reported1.9
Earnings Announcement for Period Ending Q1/2021:04/30/2021

Compare
1-Day Performance

-1%0+1%
-1%0+1%
Equity
AZN:LN
+0.51%
Sponsored By

About AstraZeneca PLC

AstraZeneca PLC operates as a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection.
Address
1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge, CB2 0AA United Kingdom
Phone
44-20-3749-5000
Website
www.astrazeneca.com

Executives

Name/Title
Pascal Claude Roland Soriot
CEO/Executive Director
Marc Dunoyer
CFO/Executive Director
Katarina Ageborg
Exec VP:Sustainability/Chief Compliance Ofcr
View More

Board Members

Name/Company
Leif Johansson
Marcus Wallenberg
Marc Dunoyer
AstraZeneca PLC
View More
View More

Income Statement

Quarterly
Annual
;
Q4 2020 (Millions USD)
  • Revenue
    7,410.00
  • Net Income
    1,012.00
  • Profit Margin
    13.66%

Balance Sheet

Quarterly
Annual
;
Q4 2020 (Millions USD)
  • Total Assets
    66,729.00
  • Total Liabilities
    51,091.00
  • Debt to Assets
    30.54%

Cash Flow

Quarterly
Annual
Q4 2020 (Millions USD)
  • Operating
    1,802.00
  • Investing
    134.00
  • Financing
    -2,184.00
Skip the following list of ads